In this slideshow, we highlight excerpts from a study that assesses treatment options after a Lyme disease infection. The authors question the value of delaying DMARD treatment after an autoimmune disease diagnosis.
In this news roundup, we offer a snapshot of some interesting studies we featured that pose never-ending perplexing questions: When do I switch patients from methotrexate to a biologic? Why didn't my patient report having an adverse reaction? Does vitamin D really protect bones?
Despite advancements in the understanding of the pathogenesis of gout, some patients still receive suboptimal care. In this slideshow, we highlight recommendations for improvement as stated by the experts.
The ACR workforce study, options for methotrexate, safe doses for glucocorticoids, the value of vitamin D supplements, the dangers of chikungunya, and new treatments for giant cell arteritis were among our most popular stories this year. Here's a quick look back at 2016.